 Connection
Ginell Post to Lymphoma
This is a "connection" page, showing publications Ginell Post has written about Lymphoma.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.461 |
|
|
|
-
McCrury M, Swafford K, Shuttleworth SL, Mehdi SH, Acharya B, Saha D, Naceanceno K, Byrum SD, Storey AJ, Xu YZ, Doshier C, Patel V, Post GR, De Loose A, Rodriguez A, Shultz LD, Zhan F, Yoon D, Frett B, Kendrick S. Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma. Mol Cancer Ther. 2024 Mar 04; 23(3):316-329.
Score: 0.222
-
Gralewski J, Post GR. Cutaneous intralymphatic CD30+ pseudolymphoma: a reactive condition mimicking lymphoma. Blood. 2018 10 25; 132(17):1859.
Score: 0.153
-
Desouki MM, Post GR, Cherry D, Lazarchick J. PAX-5: a valuable immunohistochemical marker in the differential diagnosis of lymphoid neoplasms. Clin Med Res. 2010 Jul; 8(2):84-8.
Score: 0.086
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|